ArticleJournal of diabetes research2026
The Association Between Amino Acids and the Onset and Progression of Type 2 Diabetes Mellitus: A Comprehensive Analysis Based on UK Biobank Database.
Article in Journal of diabetes research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The Association Between Amino Acids and the Onset and Progression of Type 2 Diabetes Mellitus: A Comprehensive Analysis Based on UK Biobank Database.Journal of diabetes research · 2026Article
- Dysregulation of Plasma Nonessential Amino Acids in Early-Stage Type 2 Diabetes Mellitus.Journal of nutrition and metabolism · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Recent studies have demonstrated an association between amino acids (AAs) and the occurrence of Type 2 diabetes mellitus (T2DM). However, whether there is an underlying causal relationship between AAs and T2DM, as well as their potential links to T2DM progression, complications, and treatment selection, still lacks sufficient clinical evidence. Methods: This study included 205,208 participants from the UKB database, with 14,066 diagnosed with T2DM. We used LASSO regression, supplemented by Mendelian randomization (MR), to explore the causal relationship between AA levels and T2DM. Additionally, restricted cubic splines, receiver operating characteristic (ROC) curves, and multivariable-adjusted regression models were applied to analyze the association between AA levels, insulin resistance, secondary complications, and treatment options for T2DM. Results: Alanine and valine were positively associated with T2DM, while glutamine, glycine, and histidine were negatively associated with T2DM. In particular, the MR results indicated a causal relationship between T2DM and plasma glutamine and glycine, which were identified as protective factors. Other branched-chain AAs, such as leucine and isoleucine, did not show significant positive associations in the regression analysis. Additionally, we integrated various AAs to develop a predictive model for secondary complications of T2DM. The model demonstrated high predictive accuracy for a range of T2DM-related complications (all areas under the ROC curve > 0.730). In addition, specific AA profiles were related to insulin resistance and demand for insulin or oral hypoglycemic drug treatment. Conclusion: Our study results demonstrate a close relationship between AA levels and the occurrence, development, and treatment demand for T2DM, offering potential biomarkers for predicting complications and guiding personalized treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.